Health IQ is an insurance technology company using science and data to negotiate special rates on insurance for health conscious communities like runners, cyclists, vegans, yogis, weightlifters, etc.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/31/2020 | Series E-1 | $15.7MM | $xx.xx | $44.16B | Bramalea Partners, G Squared | |
Price per Share
$xx.xx
Shares Outstanding
15,140,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bramalea Partners, G Squared
|
||||||
12/31/2020 | Series E | $43.55MM | $xx.xx | $44.16B | Bramalea Partners, G Squared | |
Price per Share
$xx.xx
Shares Outstanding
22,594,035
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bramalea Partners, G Squared
|
||||||
05/08/2019 | Series D | $35.24MM | $xx.xx | $18.75B | Andreessen Horowitz, Aquiline Technology Growth, Greenspring Associates, Hanwha Asset Management | |
Price per Share
$xx.xx
Shares Outstanding
32,288,935
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Aquiline Technology Growth, Greenspring Associates, Hanwha Asset Management
|
||||||
11/15/2017 | Series C | $22.99MM | $xx.xx | $9.81B | Andreessen Horowitz, Charles River Ventures, First Round Capital, Foundation Capital | |
Price per Share
$xx.xx
Shares Outstanding
29,457,156
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Charles River Ventures, First Round Capital, Foundation Capital
|
||||||
12/01/2016 | Series B | $10.1MM | $xx.xx | $4.06B | Charles River Ventures, Felicis Ventures, First Round Capital, Foundation Capital, Ribbit Capital, Western Technology Investments | |
Price per Share
$xx.xx
Shares Outstanding
29,147,008
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Charles River Ventures, Felicis Ventures, First Round Capital, Foundation Capital, Ribbit Capital, Western Technology Investments
|
||||||
12/01/2016 | Series B-1 | $4.44MM | $xx.xx | $4.06B | Charles River Ventures, Felicis Ventures, First Round Capital, Foundation Capital, Ribbit Capital, Western Technology Investments | |
Price per Share
$xx.xx
Shares Outstanding
9,847,544
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Charles River Ventures, Felicis Ventures, First Round Capital, Foundation Capital, Ribbit Capital, Western Technology Investments
|
||||||
12/15/2014 | Series A | $3.6MM | $xx.xx | $800MM | Charles River Ventures, First Round Capital, Greylock Partners, Menlo Ventures, Rock Health, Western Technology Investments | |
Price per Share
$xx.xx
Shares Outstanding
19,531,250
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Charles River Ventures, First Round Capital, Greylock Partners, Menlo Ventures, Rock Health, Western Technology Investments
|